Login/Sign Up
MRP ₹10500
(Inclusive of all Taxes)
₹1575.0 Cashback (15%)
Fulveside 250 mg Injection 5 ml is used to treat breast cancer in postmenopausal women. It contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth. In some cases, Fulveside 250 mg Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain.
Provide Delivery Location
About Fulveside 250 mg Injection 5 ml
Fulveside 250 mg Injection 5 ml belongs to the class of estrogen blockers used to treat breast cancer in postmenopausal women. Breast cancer is a type of cancer that develops when the breast cells begin to grow abnormally.
Fulveside 250 mg Injection 5 ml contains Fulvestrant, which works by inhibiting some of the actions of estrogen (female sex hormone which may help cancer cells grow in women with breast cancer) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Fulveside 250 mg Injection 5 ml will be administered by a healthcare professional; do not self-administer. In some cases, Fulveside 250 mg Injection 5 ml may cause certain common side effects such as injection site reactions like pain and/or inflammation, weakness, nausea, tiredness, headache or joint and musculoskeletal pain. Most of these side effects of Fulveside 250 mg Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulveside 250 mg Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Fulveside 250 mg Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulveside 250 mg Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Fulveside 250 mg Injection 5 ml.
Uses of Fulveside 250 mg Injection 5 ml
Have a query?
Directions for Use
Medicinal Benefits
Fulveside 250 mg Injection 5 ml contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Fulveside 250 mg Injection 5 ml may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).
How Fulveside 250 mg Injection 5 ml Works
Storage
What if I have taken an overdose of Fulveside 250 mg Injection 5 ml
Drug Warnings
If you are allergic to Fulvestrant or any other medicines, please tell your doctor. Fulveside 250 mg Injection 5 ml is not recommended for pregnant women as it may harm an unborn baby. Using effective contraception while being treated with Fulveside 250 mg Injection 5 ml and for two years after the last dose is advised. Fulveside 250 mg Injection 5 ml is contraindicated for use during lactation. Avoid alcohol consumption while receiving Fulveside 250 mg Injection 5 ml. Avoid driving or operating machinery if you feel tired or weak after receiving Fulveside 250 mg Injection 5 ml.
Diet & Lifestyle Advise
Habit Forming
Therapeutic Class
Alcohol
Caution
Avoid alcohol consumption while receiving this medicine. If you have any concerns, please discuss them with your doctor.
Pregnancy
Unsafe
Fulveside 250 mg Injection 5 ml is not recommended for use during pregnancy as it may harm the unborn baby. You are advised to use effective contraception while being treated with Fulveside 250 mg Injection 5 ml and for two years after your last dose.
Breast Feeding
Unsafe
Fulveside 250 mg Injection 5 ml is contraindicated for use during lactation, or you are recommended to avoid breastfeeding while on treatment with Fulveside 250 mg Injection 5 ml.
Driving
Safe if prescribed
Fulveside 250 mg Injection 5 ml usually does not affect your ability to drive or operate machinery. However, avoid driving or operating machinery if you feel tired or weak after receiving Fulveside 250 mg Injection 5 ml.
Liver
Caution
Fulveside 250 mg Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have liver problems, inform your doctor before receiving Fulveside 250 mg Injection 5 ml.
Kidney
Caution
If you have kidney problems, inform your doctor before receiving Fulveside 250 mg Injection 5 ml.
Children
Unsafe
Fulveside 250 mg Injection 5 ml is not recommended for children and adolescents below 18 years of age.
Fulveside 250 mg Injection 5 ml is used to treat Breast cancer in postmenopausal women.
Fulveside 250 mg Injection 5 ml contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.
Fulveside 250 mg Injection 5 ml is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Fulveside 250 mg Injection 5 ml.
Fulveside 250 mg Injection 5 ml may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.
Fulveside 250 mg Injection 5 ml contains Fulvestrant, which belongs to a class of medications called estrogen receptor antagonists. It helps to slow or stop the growth of specific breast tumours that depend on estrogen (a female sex hormone) to grow.
Fulveside 250 mg Injection 5 ml is administered as a liquid injection into a muscle in the buttocks by a doctor in a medical setting. It is typically injected slowly over 1 to 2 minutes. For the first three doses, you will receive an injection every two weeks (on days 1, 15, and 29). After that, it is usually given once a month. Your doctor will determine the exact schedule based on your condition and how you respond to the medication. The injection will be given as two separate shots (one in each buttock). Please do not self-administer it.
Fulveside 250 mg Injection 5 ml may cause common side effects, such as injection site reactions like pain and inflammation, weakness, nausea, tiredness, headache, or joint and musculoskeletal pain in some individuals. Most of these side effects of Fulveside 250 mg Injection 5 ml do not require medical attention and gradually resolve over time. However, if these side effects persist or worsen, please consult your doctor.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Buy best Neoplastic Disorders products by
Intas Pharmaceuticals Ltd
Dr Reddy's Laboratories Ltd
Natco Pharma Ltd
Celon Laboratories Pvt Ltd
Cipla Ltd
Sun Pharmaceutical Industries Ltd
BDR Pharmaceuticals Internationals Pvt Ltd
Adley Formulations
Admac Lifesciences(Oncology)
Alkem Laboratories Ltd
Neon Laboratories Ltd
Glenmark Pharmaceuticals Ltd
United Biotech Pvt Ltd
Halsted Pharma Pvt Ltd
Emcure Pharmaceuticals Ltd
Zydus Healthcare Ltd
Zydus Cadila
Samarth Life Sciences Pvt Ltd
Mylan Pharmaceuticals Pvt Ltd
Hetero Drugs Ltd
GLS Pharma Ltd
Axiommax Oncology Pvt Ltd
Fresenius Kabi India Pvt Ltd
Hetero Healthcare Pvt Ltd
Torrent Pharmaceuticals Ltd
Pfizer Ltd
Getwell Life Sciences India Pvt Ltd
Khandelwal Laboratories Pvt Ltd
Lupin Ltd
Adley Pharmaceuticals Ltd
Cadila Healthcare Ltd
Aureate Healthcare
Novartis India Ltd
Therdose Pharma Pvt Ltd
RPG Life Sciences Ltd
Abbott India Ltd
Biochem Pharmaceutical Industries Ltd
Delarc Pharmaceuticals Pvt Ltd
Aimcad Biotech Pvt Ltd
Reliance Formulation Pvt Ltd
Shilpa Medicare Ltd
Wembrace Biopharma Pvt Ltd
Zee Laboratories Ltd
Msn Laboratories Pvt Ltd
Amps Biotech Biotech Pvt Ltd
Astra Zeneca Pharma India Ltd
Getwell Oncology Pvt Ltd
Caitlin Oncology
Medaegis Biotek Pvt Ltd
Dabur India Ltd
Del Trade International Pvt Ltd
MEDICAMEN BIOTECH LTD
Medion Biotech Pvt Ltd
Oncostar Pharma Pvt Ltd
Panacea Biotec Ltd
Sarabhai Chemicals (India) Pvt Ltd
Bhardwaj India Pvt Ltd
Getwell Pharmaceutical Pvt Ltd
Cytogen
Lucien Life Sciences
Symbion Lifescience
Bangalore Pharmaceutical and Research Laboratory Pvt Ltd (BPRL)
Cadila Pharmaceuticals Ltd
Miracalus Pharma Pvt Ltd
Vhb Life Sciences Inc
Allieva Pharma Pvt Ltd
Amneal Healthcare Pvt Ltd
Ipca Laboratories Ltd
Zuvius Lifesciences Pvt Ltd
Eli Lilly and Company (India) Pvt Ltd
Eris Life Sciences Ltd
Johnson & Johnson Pvt Ltd
Maximal Healthcare Pvt Ltd
Admac Pharma Ltd
Akumentis Healthcare Ltd
Biocon Ltd
Bruck Pharma Pvt Ltd
Caitlin Biotech Pvt Ltd
Ferring Pharmaceuticals Pvt Ltd
Fresenius Kabi Oncology Ltd
Hilfen Pharmaceuticals Pvt Ltd
Medicamen Biotech Ltd
Sayre Therapeutics Pvt Ltd
Zuventus Healthcare Ltd
Boehringer Ingelheim India Pvt Ltd
Selway Lifesciences Pvt Ltd
Trikem Remedies Llp
Adley Oncology
Corona Remedies Pvt Ltd
Eisai Pharmaceuticals India Pvt Ltd
GlaxoSmithKline Pharmaceuticals Ltd
Gynofem Healthcare Pvt Ltd
Hillrock Biotech Pvt Ltd
Janssen Pharmaceuticals Pvt Ltd
Jodas Expoim Pvt Ltd
Mankind Pharma Pvt Ltd
Merck Ltd
Oncobiotek Drugs Pvt Ltd
Pharm Products Pvt Ltd
Rhone Poulenc Rorer India Pvt Ltd